372 related articles for article (PubMed ID: 28692169)
1. The relationship between anxiety and quality of life in children with hereditary angioedema.
Kessel A; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Engel-Yeger B
Pediatr Allergy Immunol; 2017 Nov; 28(7):692-698. PubMed ID: 28692169
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life among children with hereditary angioedema.
Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in Danish children with hereditary angioedema.
Aabom A; Nguyen D; Fisker N; Bygum A
Allergy Asthma Proc; 2017 Nov; 38(6):440-446. PubMed ID: 29046193
[TBL] [Abstract][Full Text] [Related]
4. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF
Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674
[TBL] [Abstract][Full Text] [Related]
5. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
[TBL] [Abstract][Full Text] [Related]
6. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
[TBL] [Abstract][Full Text] [Related]
7. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
8. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.
Prior N; Remor E; Pérez-Fernández E; Caminoa M; Gómez-Traseira C; Gayá F; Aabom A; Aberer W; Betschel S; Boccon-Gibod I; Bouillet L; Bygum A; Csuka D; Farkas H; Gomide M; Grumach A; Leibovich I; Malbran A; Moldovan D; Mihaly E; Obtulowicz K; Perpén C; Peveling-Oberhag A; Porebski G; Chavannes CR; Reshef A; Staubach P; Wiednig M; Caballero T
J Allergy Clin Immunol Pract; 2016; 4(3):464-473.e4. PubMed ID: 26969268
[TBL] [Abstract][Full Text] [Related]
11. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
12. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
[TBL] [Abstract][Full Text] [Related]
13. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.
Zotter Z; Nagy Z; Patócs A; Csuka D; Veszeli N; Kőhalmi KV; Farkas H
Orphanet J Rare Dis; 2017 Jan; 12(1):5. PubMed ID: 28069032
[TBL] [Abstract][Full Text] [Related]
15. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
[TBL] [Abstract][Full Text] [Related]
17. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study.
Savarese L; Bova M; Maiello A; Petraroli A; Mormile I; Cancian M; Senter R; Zanichelli A; Spadaro G; Freda MF
Orphanet J Rare Dis; 2021 Jan; 16(1):23. PubMed ID: 33422102
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks.
Lumry WR; Miller DP; Newcomer S; Fitts D; Dayno J
Allergy Asthma Proc; 2014; 35(5):371-6. PubMed ID: 25295804
[TBL] [Abstract][Full Text] [Related]
20. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
